Seeing double: the rise of digital twins in life sciences
Virtual models of life science experiments could be a springboard for innovation in complex biological digital twins, says Synthace co-founder Markus Gershater
Does the answer to advancing rare disease treatment lie in real-world data?
Real-world data is vital to expanding our understanding of rare diseases, but more data is needed to realise its full potential, says Janssen’s Neil Davie and Emmanuelle Quiles
Inside the changing tides of life science research
The R&D landscape is undergoing a transformative period of innovation. Astellas Pharma’s Bernie Zeiher discusses the changing nature of life science research
Emerging technologies that are changing the way healthcare is delivered in 2022
Advanced technologies have opened up new possibilities in healthcare delivery. Arknea’s Rahul Varshneya identifies the emerging systems set to drive change across the industry
Using cross-functional teams to develop a product’s value story
A data-driven strategy is essential to successfully communicate a brand’s value proposition in a competitive market, says ICON’s Tanya Brinsden, Jessica Cherian and Beranger Lueza
Traditional models have reinforced the perception that launching across different markets is complex. But that may not be the case, as EVERSANA’s Mike Ryan explains
Rare disease communities are among the most empowered patient populations. AXON’s Emma Lemon discusses the value of engaging rare disease patients, HCPs, and caregivers